HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,858,121 | +2.0% | 43,069 | -3.0% | 0.04% | +8.6% |
| Q2 2023 | $3,781,834 | +1.0% | 44,419 | -1.8% | 0.04% | -5.4% |
| Q1 2023 | $3,743,776 | +139801.9% | 45,242 | +33.0% | 0.04% | -9.8% |
| Q4 2022 | $2,676 | -99.9% | 34,023 | -7.8% | 0.04% | -6.8% |
| Q3 2022 | $2,732,000 | +13.5% | 36,909 | -0.1% | 0.04% | +15.8% |
| Q2 2022 | $2,408,000 | +5.1% | 36,943 | +2.0% | 0.04% | +22.6% |
| Q1 2022 | $2,291,000 | +17.2% | 36,236 | -1.7% | 0.03% | +29.2% |
| Q4 2021 | $1,954,000 | -26.6% | 36,845 | -2.3% | 0.02% | -27.3% |
| Q3 2021 | $2,661,000 | +5.2% | 37,700 | -0.7% | 0.03% | +13.8% |
| Q2 2021 | $2,530,000 | -40.0% | 37,971 | +0.0% | 0.03% | -44.2% |
| Q1 2021 | $4,215,000 | -12.9% | 37,969 | -6.9% | 0.05% | -14.8% |
| Q4 2020 | $4,842,000 | +17.2% | 40,771 | -13.9% | 0.06% | +8.9% |
| Q3 2020 | $4,132,000 | +15.9% | 47,362 | +19.0% | 0.06% | -1.8% |
| Q2 2020 | $3,565,000 | -17.0% | 39,810 | -7.6% | 0.06% | -27.8% |
| Q1 2020 | $4,295,000 | +7.8% | 43,094 | +24.3% | 0.08% | +29.5% |
| Q4 2019 | $3,983,000 | -8.6% | 34,668 | +0.3% | 0.06% | -11.6% |
| Q3 2019 | $4,359,000 | +4.2% | 34,556 | -0.6% | 0.07% | +6.2% |
| Q2 2019 | $4,182,000 | +38.0% | 34,752 | +0.3% | 0.06% | +35.4% |
| Q1 2019 | $3,030,000 | -10.5% | 34,633 | +2.4% | 0.05% | -20.0% |
| Q4 2018 | $3,384,000 | -9.2% | 33,821 | +4.0% | 0.06% | +17.6% |
| Q3 2018 | $3,727,000 | +23.3% | 32,525 | -3.5% | 0.05% | +24.4% |
| Q2 2018 | $3,022,000 | +16.7% | 33,695 | -4.8% | 0.04% | +17.1% |
| Q1 2018 | $2,589,000 | +24.8% | 35,383 | -0.9% | 0.04% | +34.6% |
| Q4 2017 | $2,074,000 | +20.4% | 35,703 | -7.0% | 0.03% | +18.2% |
| Q3 2017 | $1,723,000 | +13.9% | 38,405 | +0.3% | 0.02% | +10.0% |
| Q2 2017 | $1,513,000 | -1.0% | 38,304 | +1.7% | 0.02% | 0.0% |
| Q1 2017 | $1,528,000 | +0.9% | 37,651 | -0.1% | 0.02% | 0.0% |
| Q4 2016 | $1,515,000 | +7.1% | 37,677 | -3.6% | 0.02% | +5.3% |
| Q3 2016 | $1,415,000 | +25.1% | 39,078 | +0.1% | 0.02% | +26.7% |
| Q2 2016 | $1,131,000 | -20.5% | 39,029 | -4.0% | 0.02% | -16.7% |
| Q1 2016 | $1,422,000 | +4.8% | 40,654 | -3.4% | 0.02% | +5.9% |
| Q4 2015 | $1,357,000 | -0.2% | 42,105 | +0.1% | 0.02% | 0.0% |
| Q3 2015 | $1,360,000 | -25.2% | 42,066 | -4.3% | 0.02% | -19.0% |
| Q2 2015 | $1,819,000 | -12.7% | 43,968 | -5.2% | 0.02% | -8.7% |
| Q1 2015 | $2,083,000 | +20.5% | 46,377 | +0.3% | 0.02% | +21.1% |
| Q4 2014 | $1,729,000 | +6.1% | 46,217 | -0.9% | 0.02% | +5.6% |
| Q3 2014 | $1,629,000 | -12.3% | 46,640 | -11.4% | 0.02% | -5.3% |
| Q2 2014 | $1,857,000 | +8.8% | 52,626 | +0.5% | 0.02% | +5.6% |
| Q1 2014 | $1,707,000 | -25.3% | 52,375 | -3.4% | 0.02% | -21.7% |
| Q4 2013 | $2,284,000 | +5.3% | 54,215 | -0.4% | 0.02% | +4.5% |
| Q3 2013 | $2,170,000 | -8.4% | 54,424 | -5.0% | 0.02% | -12.0% |
| Q2 2013 | $2,368,000 | -2.1% | 57,274 | -1.4% | 0.02% | 0.0% |
| Q1 2013 | $2,420,000 | – | 58,083 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |